About Murli Krishna Pharma
Murli Krishna Pharma is a company based in Pune (India) founded in 2004 by Vijay K. Shastri and Satya Vadlamani. Murli Krishna Pharma has raised $11.19 million across 6 funding rounds from investors including InvAscent, Bowland Investment and Murli Krishna Exports. The company has 218 employees as of November 11, 2024. Murli Krishna Pharma offers products and services including Tablets, Capsules, Injectables, and Oral Liquids.
- Headquarter Pune, India
- Employees 218 as on 11 Nov, 2024
- Founders Vijay K. Shastri, Satya Vadlamani
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Murli Krishna Pharma Private Limited
- Date of Incorporation 02 Apr, 2004
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$21.79 M (USD)73.02as on Mar 31, 2024
-
Net Profit
$775.55 K (USD)835.95as on Mar 31, 2024
-
EBITDA
$1.9 M (USD)343.35as on Mar 31, 2024
-
Total Equity Funding
$11.19 M (USD)
in 6 rounds
-
Latest Funding Round
$9.26 M (USD), Series A
May 25, 2020
-
Investors
InvAscent
& 13 more
-
Employee Count
218
as on Nov 11, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Murli Krishna Pharma
Murli Krishna Pharma offers a comprehensive portfolio of products and services, including Tablets, Capsules, Injectables, and Oral Liquids.
Formulations for accurate dosing and drug distribution
Encapsulation for customized drug delivery
Solutions for therapeutic administration
Formulations for patient bioavailability
Funding Insights of Murli Krishna Pharma
Murli Krishna Pharma has successfully raised a total of $11.19M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $9.26 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Murli Krishna Pharma
Murli Krishna Pharma has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include InvAscent, Bowland Investment and Murli Krishna Exports.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life sciences investments in India.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Manufactures and exports pharmaceutical, veterinary, cosmetics, and animal feed ingredients to international markets.
|
Locked | Locked | Locked |
Investor details for Murli Krishna Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Murli Krishna Pharma
Investment portfolio details for Murli Krishna Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Murli Krishna Pharma
Detailed financials for Murli Krishna Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Murli Krishna Pharma Comparisons
Peer comparison for Murli Krishna Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Murli Krishna Pharma
Detailed competitors of Murli Krishna Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Murli Krishna Pharma
Complete news archive for Murli Krishna Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Murli Krishna Pharma
Murli Krishna Pharma was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Murli Krishna Pharma is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Murli Krishna Pharma is a funded company, having raised a total of $11.19M across 6 funding rounds to date.
As of Nov 11, 2024, the latest employee count at Murli Krishna Pharma is 218.
Annual revenue of Murli Krishna Pharma is $21.79M as on Mar 31, 2024.
Murli Krishna Pharma was established in 2004 and is based in Pune, India. Operations are centered in the pharmaceutical sector, with a focus on manufacturing intermediate drugs for formulations. The company is led by co-founders Vijay K. Shastri, serving as Director, and Satya Vadlamani, acting as Chairman. Production activities support drug development processes in the region.
Murli Krishna Pharma offers Tablets, Capsules, Injectables, and Oral Liquids.
Murli Krishna Pharma has 14 investors. Key investors include InvAscent, Bowland Investment, Murli Krishna Exports, Hamza Investment, and Umoja.
The valuation of Murli Krishna Pharma is $4.15M as of Aug 2014.